{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:07:50Z","timestamp":1778170070653,"version":"3.51.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shenzhen Medical Research Fund","award":["A2302036"],"award-info":[{"award-number":["A2302036"]}]},{"name":"Shenzhen Medical Research Fund","award":["A2302037"],"award-info":[{"award-number":["A2302037"]}]},{"name":"the Hospital Research Fund of the Seventh Affiliated Hospital of Sun Yat-sen University","award":["ZSQYLCKYJJ202310"],"award-info":[{"award-number":["ZSQYLCKYJJ202310"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M744019"],"award-info":[{"award-number":["2023M744019"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postdoctoral Fellowship Program of CPSF","award":["GZC20233251"],"award-info":[{"award-number":["GZC20233251"]}]},{"name":"Guangdong Basic and Applied Basic Research Foundatation","award":["2024A1515220026"],"award-info":[{"award-number":["2024A1515220026"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32471261"],"award-info":[{"award-number":["32471261"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82272689"],"award-info":[{"award-number":["82272689"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Zhujiang Talent Program","award":["2019QN01Y305"],"award-info":[{"award-number":["2019QN01Y305"]}]},{"name":"Regional Joint Key Project of Guangdong Province","award":["2022B1515120038"],"award-info":[{"award-number":["2022B1515120038"]}]},{"name":"Guangdong Provincial Key Laboratory of Digestive Cancer Research","award":["2021B1212040006"],"award-info":[{"award-number":["2021B1212040006"]}]},{"name":"Shenzhen Science and Technology Program","award":["JCYJ20220818102018038"],"award-info":[{"award-number":["JCYJ20220818102018038"]}]},{"name":"the Sanming Project of Medicine in Shenzhen","award":["SZSM202011011"],"award-info":[{"award-number":["SZSM202011011"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-04103-2","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T11:15:02Z","timestamp":1752318902000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TGF-\u03b23 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy"],"prefix":"10.1007","volume":"74","author":[{"given":"Qiliang","family":"Teng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanqi","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tongyu","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yupeng","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimian","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ran","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuanqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fu-Ying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"issue":"1","key":"4103_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.euf.2017.10.014","volume":"4","author":"SP Kelly","year":"2018","unstructured":"Kelly SP, Anderson WF, Rosenberg PS, Cook MB (2018) Past, current, and future incidence rates and burden of metastatic prostate cancer in the United States. Eur Urol Focus 4(1):121\u2013127","journal-title":"Eur Urol Focus"},{"issue":"7","key":"4103_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158952","volume":"11","author":"V Conteduca","year":"2016","unstructured":"Conteduca V, Crabb SJ, Jones RJ et al (2016) Persistent neutrophil to lymphocyte ratio >3 during treatment with enzalutamide and clinical outcome in patients with castration-resistant prostate cancer. PLoS ONE 11(7):e0158952","journal-title":"PLoS ONE"},{"issue":"1","key":"4103_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1001\/jama.2015.6036","volume":"314","author":"MR Cooperberg","year":"2015","unstructured":"Cooperberg MR, Carroll PR (2015) Trends in management for patients with localized prostate cancer, 1990\u20132013. JAMA 314(1):80\u201382","journal-title":"JAMA"},{"issue":"1","key":"4103_CR4","first-page":"14","volume":"11","author":"CJ Paller","year":"2013","unstructured":"Paller CJ, Antonarakis ES (2013) Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions. Clin Adv Hematol Oncol 11(1):14\u201323","journal-title":"Clin Adv Hematol Oncol"},{"issue":"4","key":"4103_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10555-015-9597-6","volume":"34","author":"M Santoni","year":"2015","unstructured":"Santoni M, Piva F, Scarpelli M et al (2015) The origin of prostate metastases: emerging insights. Cancer Metastasis Rev 34(4):765\u2013773","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"4103_CR6","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/14737140.2017.1333903","volume":"17","author":"A Anantharaman","year":"2017","unstructured":"Anantharaman A, Small EJ (2017) Tackling non-metastatic castration-resistant prostate cancer: special considerations in treatment. Expert Rev Anticancer Ther 17(7):625\u2013633","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"4103_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41391-017-0023-8","volume":"21","author":"J Gandhi","year":"2018","unstructured":"Gandhi J, Afridi A, Vatsia S et al (2018) The molecular biology of prostate cancer: current understanding and clinical implications. Prostate Cancer Prostatic Dis 21(1):22\u201336","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"10","key":"4103_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101199","volume":"4","author":"D Sridaran","year":"2023","unstructured":"Sridaran D, Bradshaw E, DeSelm C, Pachynski R, Mahajan K, Mahajan NP (2023) Prostate cancer immunotherapy: improving clinical outcomes with a multi-pronged approach. Cell Rep Med 4(10):101199","journal-title":"Cell Rep Med"},{"key":"4103_CR9","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021873","author":"M Morikawa","year":"2016","unstructured":"Morikawa M, Derynck R, Miyazono K (2016) TGF-\u03b2 and the TGF-\u03b2 family: context-dependent roles in cell and tissue physiology. Cold Spring Harb Perspect Biol. https:\/\/doi.org\/10.1101\/cshperspect.a021873","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"4103_CR10","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022186","volume":"9","author":"AC Mullen","year":"2017","unstructured":"Mullen AC, Wrana JL (2017) TGF-\u03b2 family signaling in embryonic and somatic stem-cell renewal and differentiation. Cold Spring Harb Perspect Biol 9(7):a022186","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"4103_CR11","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022236","volume":"9","author":"S Sanjabi","year":"2017","unstructured":"Sanjabi S, Oh SA, Li MO (2017) Regulation of the immune response by TGF-\u03b2: from conception to autoimmunity and infection. Cold Spring Harb Perspect Biol 9(6):a022236","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"7","key":"4103_CR12","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/s41580-018-0007-0","volume":"19","author":"CJ David","year":"2018","unstructured":"David CJ, Massagu\u00e9 J (2018) Contextual determinants of TGF\u03b2 action in development, immunity and cancer. Nat Rev Mol Cell Biol 19(7):419\u2013435","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"4103_CR13","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a022103","volume":"8","author":"AP Hinck","year":"2016","unstructured":"Hinck AP, Mueller TD, Springer TA (2016) Structural biology and evolution of the TGF-\u03b2 family. Cold Spring Harb Perspect Biol 8(12):a022103","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"4103_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/jdb4020021","volume":"4","author":"R Gilbert","year":"2016","unstructured":"Gilbert R, Vickaryous MK, Viloria-Petit AM (2016) Signalling by transforming growth factor beta isoforms in wound healing and tissue regeneration. J Dev Biol 4(2):21","journal-title":"J Dev Biol"},{"key":"4103_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-immunol-032713-120257","volume":"32","author":"MA Travis","year":"2014","unstructured":"Travis MA, Sheppard D (2014) TGF-\u03b2 activation and function in immunity. Annu Rev Immunol 32:51\u201382","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"4103_CR16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20190103","volume":"217","author":"N Frangogiannis","year":"2020","unstructured":"Frangogiannis N (2020) Transforming growth factor-\u03b2 in tissue fibrosis. J Exp Med 217(3):e20190103","journal-title":"J Exp Med"},{"issue":"1","key":"4103_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41571-020-0403-1","volume":"18","author":"R Derynck","year":"2021","unstructured":"Derynck R, Turley SJ, Akhurst RJ (2021) TGF\u03b2 biology in cancer progression and immunotherapy. Nat Rev Clin Oncol 18(1):9\u201334","journal-title":"Nat Rev Clin Oncol"},{"issue":"3","key":"4103_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.21037\/tau.2020.03.02","volume":"9","author":"Q Cai","year":"2020","unstructured":"Cai Q, Chen Y, Zhang D et al (2020) Loss of epithelial AR increase castration resistant stem-like prostate cancer cells and promotes cancer metastasis via TGF-\u03b21\/EMT pathway. Transl Androl Urol 9(3):1013\u20131027","journal-title":"Transl Androl Urol"},{"issue":"6","key":"4103_CR19","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1210\/en.2017-00086","volume":"158","author":"H Pu","year":"2017","unstructured":"Pu H, Begemann DE, Kyprianou N (2017) Aberrant TGF-\u03b2 signaling drives castration-resistant prostate cancer in a male mouse model of prostate tumorigenesis. Endocrinology 158(6):1612\u20131622","journal-title":"Endocrinology"},{"issue":"2","key":"4103_CR20","doi-asserted-by":"publisher","first-page":"162","DOI":"10.4161\/onci.1.2.18481","volume":"1","author":"MK Donkor","year":"2012","unstructured":"Donkor MK, Sarkar A, Li MO (2012) Tgf-\u03b21 produced by activated CD4(+) T cells antagonizes T cell Surveillance of tumor development. Oncoimmunology 1(2):162\u2013171","journal-title":"Oncoimmunology"},{"issue":"4","key":"4103_CR21","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1089\/ten.teb.2018.0350","volume":"25","author":"M Monavarian","year":"2019","unstructured":"Monavarian M, Kader S, Moeinzadeh S, Jabbari E (2019) Regenerative scar-free skin wound healing. Tissue Eng Part B Rev 25(4):294\u2013311","journal-title":"Tissue Eng Part B Rev"},{"issue":"2","key":"4103_CR22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/wrr.12398","volume":"24","author":"MK Lichtman","year":"2016","unstructured":"Lichtman MK, Otero-Vinas M, Falanga V (2016) Transforming growth factor beta (TGF-\u03b2) isoforms in wound healing and fibrosis. Wound Repair Regen 24(2):215\u2013222","journal-title":"Wound Repair Regen"},{"issue":"2","key":"4103_CR23","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/cmi.2012.72","volume":"10","author":"M Sharma","year":"2013","unstructured":"Sharma M, Kaveri SV, Bayry J (2013) Th17 cells, pathogenic or not? TGF-\u03b23 imposes the embargo. Cell Mol Immunol 10(2):101\u2013102","journal-title":"Cell Mol Immunol"},{"issue":"6","key":"4103_CR24","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nri2095","volume":"7","author":"YP Rubtsov","year":"2007","unstructured":"Rubtsov YP, Rudensky AY (2007) TGFbeta signalling in control of T-cell-mediated self-reactivity. Nat Rev Immunol 7(6):443\u2013453","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"4103_CR25","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1016\/j.autrev.2016.07.007","volume":"15","author":"K Fujio","year":"2016","unstructured":"Fujio K, Komai T, Inoue M, Morita K, Okamura T, Yamamoto K (2016) Revisiting the regulatory roles of the TGF-\u03b2 family of cytokines. Autoimmun Rev 15(9):917\u2013922","journal-title":"Autoimmun Rev"},{"key":"4103_CR26","first-page":"29","volume":"410","author":"K Fujio","year":"2017","unstructured":"Fujio K, Yamamoto K, Okamura T (2017) Overview of LAG-3-expressing, IL-10-producing regulatory T cells. Curr Top Microbiol Immunol 410:29\u201345","journal-title":"Curr Top Microbiol Immunol"},{"key":"4103_CR27","doi-asserted-by":"publisher","first-page":"6329","DOI":"10.1038\/ncomms7329","volume":"6","author":"T Okamura","year":"2015","unstructured":"Okamura T, Sumitomo S, Morita K, Iwasaki Y, Inoue M, Nakachi S, Komai T, Shoda H, Miyazaki J, Fujio K et al (2015) TGF-\u03b23-expressing CD4+CD25(-)LAG3+ regulatory T cells control humoral immune responses. Nat Commun 6:6329","journal-title":"Nat Commun"},{"issue":"6","key":"4103_CR28","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1172\/JCI114932","volume":"86","author":"LM Wakefield","year":"1990","unstructured":"Wakefield LM, Winokur TS, Hollands RS, Christopherson K, Levinson AD, Sporn MB (1990) Recombinant latent transforming growth factor beta 1 has a longer plasma half-life in rats than active transforming growth factor beta 1, and a different tissue distribution. J Clin Invest 86(6):1976\u20131984","journal-title":"J Clin Invest"},{"issue":"5706","key":"4103_CR29","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307(5706):58\u201362","journal-title":"Science"},{"issue":"6","key":"4103_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/nrd3455","volume":"10","author":"P Carmeliet","year":"2011","unstructured":"Carmeliet P, Jain RK (2011) Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov 10(6):417\u2013427","journal-title":"Nat Rev Drug Discov"},{"issue":"25","key":"4103_CR31","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1073\/pnas.93.25.14765","volume":"93","author":"F Yuan","year":"1996","unstructured":"Yuan F, Chen Y, Dellian M, Safabakhsh N, Ferrara N, Jain RK (1996) Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an antivascular endothelial growth factor\/vascular permeability factor antibody. Proc Natl Acad Sci USA 93(25):14765\u201314770","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"4103_CR32","doi-asserted-by":"publisher","first-page":"3731","DOI":"10.1158\/0008-5472.CAN-04-0074","volume":"64","author":"RT Tong","year":"2004","unstructured":"Tong RT, Boucher Y, Kozin SV, Winkler F, Hicklin DJ, Jain RK (2004) Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64(11):3731\u20133736","journal-title":"Cancer Res"},{"issue":"6","key":"4103_CR33","first-page":"553","volume":"6","author":"F Winkler","year":"2004","unstructured":"Winkler F, Kozin SV, Tong RT, Chae SS, Booth MF, Garkavtsev I, Xu L, Hicklin DJ, Fukumura D, di Tomaso E et al (2004) Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases. Cancer Cell 6(6):553\u2013563","journal-title":"Cancer Cell"},{"issue":"11","key":"4103_CR34","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nri3908","volume":"15","author":"D Vestweber","year":"2015","unstructured":"Vestweber D (2015) How leukocytes cross the vascular endothelium. Nat Rev Immunol 15(11):692\u2013704","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"4103_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/cti.2017.7","volume":"6","author":"LY Tan","year":"2017","unstructured":"Tan LY, Martini C, Fridlender ZG, Bonder CS, Brown MP, Ebert LM (2017) Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy. Clin Transl Immunol 6(3):e134","journal-title":"Clin Transl Immunol"},{"issue":"8","key":"4103_CR36","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1038\/jid.2013.36","volume":"133","author":"OK Afanasiev","year":"2013","unstructured":"Afanasiev OK, Nagase K, Simonson W, Vandeven N, Blom A, Koelle DM, Clark R, Nghiem P (2013) Vascular E-selectin expression correlates with CD8 lymphocyte infiltration and improved outcome in Merkel cell carcinoma. J Invest Dermatol 133(8):2065\u20132073","journal-title":"J Invest Dermatol"},{"issue":"7927","key":"4103_CR37","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1038\/d41586-022-02861-y","volume":"609","author":"A King","year":"2022","unstructured":"King A (2022) Could immunotherapy finally break through in prostate cancer. Nature 609(7927):S42-42S44","journal-title":"Nature"},{"issue":"3","key":"4103_CR38","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nri.2017.145","volume":"18","author":"Y Huang","year":"2018","unstructured":"Huang Y, Kim B, Chan CK, Hahn SM, Weissman IL, Jiang W (2018) Improving immune-vascular crosstalk for cancer immunotherapy. Nat Rev Immunol 18(3):195\u2013203","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"4103_CR39","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/nm1699","volume":"14","author":"RJ Buckanovich","year":"2008","unstructured":"Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, Katsaros D, O\u2019Brien-Jenkins A, Gimotty PA, Coukos G (2008) Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nat Med 14(1):28\u201336","journal-title":"Nat Med"},{"issue":"15","key":"4103_CR40","first-page":"4265","volume":"52","author":"NZ Wu","year":"1992","unstructured":"Wu NZ, Klitzman B, Dodge R, Dewhirst MW (1992) Diminished leukocyte-endothelium interaction in tumor microvessels. Cancer Res 52(15):4265\u20134268","journal-title":"Cancer Res"},{"key":"4103_CR41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev-pathol-011110-130224","volume":"6","author":"WA Muller","year":"2011","unstructured":"Muller WA (2011) Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 6:323\u2013344","journal-title":"Annu Rev Pathol"},{"issue":"8","key":"4103_CR42","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","volume":"95","author":"SK Hobbs","year":"1998","unstructured":"Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95(8):4607\u20134612","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"4103_CR43","first-page":"1605","volume":"5","author":"RK Jain","year":"1999","unstructured":"Jain RK (1999) Understanding barriers to drug delivery: high resolution in vivo imaging is key. Clin Cancer Res 5(7):1605\u20131606","journal-title":"Clin Cancer Res"},{"issue":"19","key":"4103_CR44","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","volume":"186","author":"J Massagu\u00e9","year":"2023","unstructured":"Massagu\u00e9 J, Sheppard D (2023) TGF-\u03b2 signaling in health and disease. Cell 186(19):4007\u20134037","journal-title":"Cell"},{"issue":"1","key":"4103_CR45","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41568-021-00413-6","volume":"22","author":"D Tauriello","year":"2022","unstructured":"Tauriello D, Sancho E, Batlle E (2022) Overcoming TGF\u03b2-mediated immune evasion in cancer. Nat Rev Cancer 22(1):25\u201344","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"4103_CR46","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/s41577-022-00796-z","volume":"23","author":"BG Nixon","year":"2023","unstructured":"Nixon BG, Gao S, Wang X, Li MO (2023) TGF\u03b2 control of immune responses in cancer: a holistic immuno-oncology perspective. Nat Rev Immunol 23(6):346\u2013362","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"4103_CR47","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.immuni.2019.03.024","volume":"50","author":"E Batlle","year":"2019","unstructured":"Batlle E, Massagu\u00e9 J (2019) Transforming growth factor-\u03b2 signaling in immunity and cancer. Immunity 50(4):924\u2013940","journal-title":"Immunity"},{"issue":"7693","key":"4103_CR48","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/nature25492","volume":"554","author":"D Tauriello","year":"2018","unstructured":"Tauriello D, Palomo-Ponce S, Stork D, Berenguer-Llergo A, Badia-Ramentol J, Iglesias M, Sevillano M, Ibiza S, Ca\u00f1ellas A, Hernando-Momblona X et al (2018) TGF\u03b2 drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 554(7693):538\u2013543","journal-title":"Nature"},{"issue":"7693","key":"4103_CR49","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, Kadel EEI, Koeppen H, Astarita JL, Cubas R et al (2018) TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature 554(7693):544\u2013548","journal-title":"Nature"},{"issue":"1","key":"4103_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0493-9","volume":"7","author":"E Dodagatta-Marri","year":"2019","unstructured":"Dodagatta-Marri E, Meyer DS, Reeves MQ, Paniagua R, To MD, Binnewies M, Broz ML, Mori H, Wu D, Adoumie M et al (2019) \u03b1-PD-1 therapy elevates Treg\/Th balance and increases tumor cell pSmad3 that are both targeted by \u03b1-TGF\u03b2 antibody to promote durable rejection and immunity in squamous cell carcinomas. J Immunother Cancer 7(1):62","journal-title":"J Immunother Cancer"},{"issue":"4","key":"4103_CR51","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.jid.2018.01.016","volume":"138","author":"C Philippeos","year":"2018","unstructured":"Philippeos C, Telerman SB, Oul\u00e8s B, Pisco AO, Shaw TJ, Elgueta R, Lombardi G, Driskell RR, Soldin M, Lynch MD et al (2018) Spatial and single-cell transcriptional profiling identifies functionally distinct human dermal fibroblast subpopulations. J Invest Dermatol 138(4):811\u2013825","journal-title":"J Invest Dermatol"},{"issue":"7760","key":"4103_CR52","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","volume":"570","author":"AP Croft","year":"2019","unstructured":"Croft AP, Campos J, Jansen K, Turner JD, Marshall J, Attar M, Savary L, Wehmeyer C, Naylor AJ, Kemble S et al (2019) Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570(7760):246\u2013251","journal-title":"Nature"},{"issue":"3","key":"4103_CR53","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, Corbo V, Oni TE, Hearn SA, Lee EJ et al (2017) Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med 214(3):579\u2013596","journal-title":"J Exp Med"},{"issue":"1","key":"4103_CR54","doi-asserted-by":"publisher","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","volume":"11","author":"J Winkler","year":"2020","unstructured":"Winkler J, Abisoye-Ogunniyan A, Metcalf KJ, Werb Z (2020) Concepts of extracellular matrix remodelling in tumour progression and metastasis. Nat Commun 11(1):5120","journal-title":"Nat Commun"},{"issue":"13","key":"4103_CR55","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1016\/j.devcel.2021.05.011","volume":"56","author":"MK Hayward","year":"2021","unstructured":"Hayward MK, Muncie JM, Weaver VM (2021) Tissue mechanics in stem cell fate, development, and cancer. Dev Cell 56(13):1833\u20131847","journal-title":"Dev Cell"},{"issue":"50","key":"4103_CR56","doi-asserted-by":"publisher","first-page":"82889","DOI":"10.18632\/oncotarget.12658","volume":"7","author":"K Takai","year":"2016","unstructured":"Takai K, Le A, Weaver VM, Werb Z (2016) Targeting the cancer-associated fibroblasts as a treatment in triple-negative breast cancer. Oncotarget 7(50):82889\u201382901","journal-title":"Oncotarget"},{"issue":"3","key":"4103_CR57","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai E, Astsaturov I, Cukierman E, DeNardo DG, Egeblad M, Evans RM, Fearon D, Greten FR, Hingorani SR, Hunter T et al (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20(3):174\u2013186","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"4103_CR58","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.annonc.2020.07.009","volume":"31","author":"D Ciardiello","year":"2020","unstructured":"Ciardiello D, Elez E, Tabernero J, Seoane J (2020) Clinical development of therapies targeting TGF\u03b2: current knowledge and future perspectives. Ann Oncol 31(10):1336\u20131349","journal-title":"Ann Oncol"},{"issue":"7","key":"4103_CR59","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/ncb807","volume":"4","author":"M Oft","year":"2002","unstructured":"Oft M, Akhurst RJ, Balmain A (2002) Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nat Cell Biol 4(7):487\u2013494","journal-title":"Nat Cell Biol"},{"issue":"5","key":"4103_CR60","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cell.2015.01.043","volume":"160","author":"N Oshimori","year":"2015","unstructured":"Oshimori N, Oristian D, Fuchs E (2015) TGF-\u03b2 promotes heterogeneity and drug resistance in squamous cell carcinoma. Cell 160(5):963\u2013976","journal-title":"Cell"},{"issue":"11","key":"4103_CR61","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1038\/ncb1973","volume":"11","author":"S Giampieri","year":"2009","unstructured":"Giampieri S, Manning C, Hooper S, Jones L, Hill CS, Sahai E (2009) Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nat Cell Biol 11(11):1287\u20131296","journal-title":"Nat Cell Biol"},{"issue":"6","key":"4103_CR62","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1242\/dev.121.6.1845","volume":"121","author":"MC Dickson","year":"1995","unstructured":"Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ (1995) Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121(6):1845\u20131854","journal-title":"Development"},{"issue":"4","key":"4103_CR63","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S1097-2765(03)00386-1","volume":"12","author":"MJ Goumans","year":"2003","unstructured":"Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta\/ALK5 signaling. Mol Cell 12(4):817\u2013828","journal-title":"Mol Cell"},{"issue":"3","key":"4103_CR64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.devcel.2012.02.005","volume":"22","author":"B Larriv\u00e9e","year":"2012","unstructured":"Larriv\u00e9e B, Prahst C, Gordon E, del Toro R, Mathivet T, Duarte A, Simons M, Eichmann A (2012) ALK1 signaling inhibits angiogenesis by cooperating with the Notch pathway. Dev Cell 22(3):489\u2013500","journal-title":"Dev Cell"},{"issue":"4","key":"4103_CR65","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1083\/jcb.106.4.1375","volume":"106","author":"JA Madri","year":"1988","unstructured":"Madri JA, Pratt BM, Tucker AM (1988) Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 106(4):1375\u20131384","journal-title":"J Cell Biol"},{"issue":"9","key":"4103_CR66","doi-asserted-by":"publisher","first-page":"6271","DOI":"10.1016\/S0021-9258(17)37365-9","volume":"269","author":"L Pertovaara","year":"1994","unstructured":"Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. J Biol Chem 269(9):6271\u20136274","journal-title":"J Biol Chem"},{"issue":"22","key":"4103_CR67","doi-asserted-by":"publisher","first-page":"7540","DOI":"10.1158\/1078-0432.CCR-04-0632","volume":"10","author":"T Hayashi","year":"2004","unstructured":"Hayashi T, Hideshima T, Nguyen AN, Munoz O, Podar K, Hamasaki M, Ishitsuka K, Yasui H, Richardson P, Chakravarty S et al (2004) Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment. Clin Cancer Res 10(22):7540\u20137546","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4103_CR68","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1038\/s41467-019-10946-y","volume":"10","author":"R Batlle","year":"2019","unstructured":"Batlle R, Andr\u00e9s E, Gonzalez L, Llonch E, Igea A, Gutierrez-Prat N, Berenguer-Llergo A, Nebreda AR (2019) Regulation of tumor angiogenesis and mesenchymal-endothelial transition by p38\u03b1 through TGF-\u03b2 and JNK signaling. Nat Commun 10(1):3071","journal-title":"Nat Commun"},{"issue":"4","key":"4103_CR69","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.cytogfr.2009.07.002","volume":"20","author":"HG Laverty","year":"2009","unstructured":"Laverty HG, Wakefield LM, Occleston NL, O\u2019Kane S, Ferguson MW (2009) TGF-beta3 and cancer: a review. Cytokine Growth Factor Rev 20(4):305\u2013317","journal-title":"Cytokine Growth Factor Rev"},{"issue":"3","key":"4103_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/path.1711710307","volume":"171","author":"P Schmid","year":"1993","unstructured":"Schmid P, Cox D, Bilbe G, McMaster G, Morrison C, St\u00e4helin H, L\u00fcscher N, Seiler W (1993) TGF-beta s and TGF-beta type II receptor in human epidermis: differential expression in acute and chronic skin wounds. J Pathol 171(3):191\u2013197","journal-title":"J Pathol"},{"issue":"2","key":"4103_CR71","first-page":"575","volume":"54","author":"U Rodeck","year":"1994","unstructured":"Rodeck U, Bossler A, Graeven U, Fox FE, Nowell PC, Knabbe C, Kari C (1994) Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells. Cancer Res 54(2):575\u2013581","journal-title":"Cancer Res"},{"issue":"3","key":"4103_CR72","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/BF01806150","volume":"38","author":"M Lambe","year":"1996","unstructured":"Lambe M, Hsieh CC, Chan HW, Ekbom A, Trichopoulos D, Adami HO (1996) Parity, age at first and last birth, and risk of breast cancer: a population-based study in Sweden. Breast Cancer Res Treat 38(3):305\u2013311","journal-title":"Breast Cancer Res Treat"},{"issue":"9","key":"4103_CR73","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1210\/me.2002-0073","volume":"16","author":"CM D'Cruz","year":"2002","unstructured":"D\u2019Cruz CM, Moody SE, Master SR, Hartman JL, Keiper EA, Imielinski MB, Cox JD, Wang JY, Ha SI, Keister BA et al (2002) Persistent parity-induced changes in growth factors, TGF-beta3, and differentiation in the rodent mammary gland. Mol Endocrinol 16(9):2034\u20132051","journal-title":"Mol Endocrinol"},{"issue":"1","key":"4103_CR74","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jnci\/94.1.50","volume":"94","author":"GC Rodriguez","year":"2002","unstructured":"Rodriguez GC, Nagarsheth NP, Lee KL, Bentley RC, Walmer DK, Cline M, Whitaker RS, Isner P, Berchuck A, Dodge RK et al (2002) Progestin-induced apoptosis in the Macaque ovarian epithelium: differential regulation of transforming growth factor-beta. J Natl Cancer Inst 94(1):50\u201360","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"4103_CR75","first-page":"93","volume":"57","author":"D Parada","year":"2004","unstructured":"Parada D, Arciniegas E, Moreira O, Trujillo E (2004) Transforming growth factor-beta2 and beta3 expression in carcinoma of the prostate. Arch Esp Urol 57(1):93\u201399","journal-title":"Arch Esp Urol"},{"issue":"6849","key":"4103_CR76","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/35090585","volume":"412","author":"SM Dhanasekaran","year":"2001","unstructured":"Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412(6849):822\u2013826","journal-title":"Nature"},{"issue":"14","key":"4103_CR77","first-page":"3877","volume":"63","author":"DK Vanaja","year":"2003","unstructured":"Vanaja DK, Cheville JC, Iturria SJ, Young CY (2003) Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res 63(14):3877\u20133882","journal-title":"Cancer Res"},{"issue":"8","key":"4103_CR78","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1158\/0008-5472.CAN-05-3055","volume":"66","author":"P Liu","year":"2006","unstructured":"Liu P, Ramachandran S, Ali Seyed M, Scharer CD, Laycock N, Dalton WB, Williams H, Karanam S, Datta MW, Jaye DL et al (2006) Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells. Cancer Res 66(8):4011\u20134019","journal-title":"Cancer Res"},{"issue":"1","key":"4103_CR79","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/ng1935","volume":"39","author":"SA Tomlins","year":"2007","unstructured":"Tomlins SA, Mehra R, Rhodes DR, Cao X, Wang L, Dhanasekaran SM, Kalyana-Sundaram S, Wei JT, Rubin MA, Pienta KJ et al (2007) Integrative molecular concept modeling of prostate cancer progression. Nat Genet 39(1):41\u201351","journal-title":"Nat Genet"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04103-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-04103-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-04103-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:22:37Z","timestamp":1757226157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-04103-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":79,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["4103"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-04103-2","relation":{},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"26 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Twelve PCa tissues were collected from the Department of Pathology at the Seventh Affiliated Hospital of Sun Yat-sen University. The acquisition and use of tissue samples passed medical ethics review and informed consent of patients (KY-2024-290-01). C57BL\/6, FVB or BALB\/c nude mice were purchased from Sibeifu (Beijing) Biotechnology Co., Ltd. All animal procedures were carried out in accordance with the Guidelines for the Care and Use of Laboratory Animals of Sun Yat-sun University (SYSU) and approved by the Animal Ethics Committee of SYSU (SYSU-IACUC-2024-002105).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"268"}}